Overview
WAVi develops non-invasive neuromodulation devices designed to treat neurological and psychiatric conditions through targeted brain stimulation. The company's technology platform focuses on delivering therapeutic interventions with enhanced precision and patient outcomes.
More in Neurotechnology
Latest industry news
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
University of Michigan Completes First Long-Term Wireless Brain-Computer Interface Implant in Humans
2026-07-07 · Research
Synchron Closes $275M Series E to Accelerate Stentrode BCI Commercialization
2026-06-29 · Funding
It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
2026-06-23 · Product
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →